HarborPath Response to COVID-19

3/16/20

In these uncertain times, the safety and wellbeing of our patients, partners, and employees remain HarborPath’s top priority.  As the Coronavirus (COVID-19) continues to impact communities throughout the US, we want to share with you our response to the evolving situation.

​

HarborPath has been closely monitoring the COVID-19 pandemic and its impact.  We believe it is our responsibility to prioritize two things:

1. Our continued commitment to support the health and safety of our patients, partners, and employees.

2. Protect our ongoing ability to distribute and process patient prescriptions.

In line with our priorities, we are implementing a variety of measures to ensure patients receive their medications:

Ensure continued patient access.  At this time, there is no impact to the supply of our medications in the US as a result of the COVID-19 pandemic.

​

To assist patients short-term, HarborPath will allow for a 30-day period beginning March 16, 2020, and ending April 6, 2020, for participating clinics, who request this support, applications will be allowed to be submitted from case managers directly to the platform without the traditional approval process.

​

This short-term support will allow clinics contingency plans from a case managers’ perspective to work from home and allow them to enroll patients who are meeting their eligibility end date and prevent an interruption in therapy for patients.

​

Patients focus remains our primary focus and we hope by making these short-term adjustments to our approval process, will allow case managers to maintain their confidence in HarborPath’s ability to serve patients' prescription needs.

​

This is a fluid situation that continues to evolve.  The HarborPath office will remain open to provide ongoing assistance to patients during this critical time. If you have any questions about your prescriptions, please do not hesitate to call our office.  We will continue to monitor the situation and share resources to keep you informed.

Sincerely,

Ken Trogdon, President at HarborPath